Antioxidative treatment for neuroprotection in glaucoma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Glaucoma is a neurodegenerative disease with progressive retinal ganglion cell apoptosis. IOP elevation is a modifiable proven risk factor for glaucoma. Although a lot of new medicines and surgeries for lowering IOP have come in, glaucoma is still a leading cause of blindness in the world, motivating us to search IOP-independent treatment. Accumulating evidences point to an association between oxidative stress and glaucoma. Increased level of oxidative DNA damage, lipid peroxidation, and protein oxidation and reduced antioxidative status were observed in serum, trabecular meshwork, and aqueous humor of human glaucoma subjects. Antioxidants protect retinal ganglion cell apoptosis from IOP elevation, optic nerve injury, inflammation, and impaired ocular blood flow in vivo and in vitro. Some population-based epidemiological studies showed that higher antioxidant intake reduced risk of glaucoma. This review focused on the present evidence that support the possibility of antioxidant neuroprotective treatment for glaucoma.

Original languageEnglish
Title of host publicationNeuroprotection and Neuroregeneration for Retinal Diseases
PublisherSpringer Japan
Pages43-66
Number of pages24
ISBN (Electronic)9784431549659
ISBN (Print)4431549641, 9784431549642
DOIs
Publication statusPublished - 2014 May 1

Fingerprint

Glaucoma
Retinal Ganglion Cells
Antioxidants
Optic Nerve Injuries
Apoptosis
Trabecular Meshwork
Aqueous Humor
Blindness
Neuroprotection
Neurodegenerative Diseases
Lipid Peroxidation
DNA Damage
Epidemiologic Studies
Oxidative Stress
Inflammation
Serum
Population
Proteins

Keywords

  • Antioxidant
  • Glaucoma
  • Mitochondria
  • Oxidative stress
  • Reactive oxygen species

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Yuki, K. (2014). Antioxidative treatment for neuroprotection in glaucoma. In Neuroprotection and Neuroregeneration for Retinal Diseases (pp. 43-66). Springer Japan. https://doi.org/10.1007/978-4-431-54965-9_4

Antioxidative treatment for neuroprotection in glaucoma. / Yuki, Kenya.

Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan, 2014. p. 43-66.

Research output: Chapter in Book/Report/Conference proceedingChapter

Yuki, K 2014, Antioxidative treatment for neuroprotection in glaucoma. in Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan, pp. 43-66. https://doi.org/10.1007/978-4-431-54965-9_4
Yuki K. Antioxidative treatment for neuroprotection in glaucoma. In Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan. 2014. p. 43-66 https://doi.org/10.1007/978-4-431-54965-9_4
Yuki, Kenya. / Antioxidative treatment for neuroprotection in glaucoma. Neuroprotection and Neuroregeneration for Retinal Diseases. Springer Japan, 2014. pp. 43-66
@inbook{7a2495865ee743f7a1b949dde4444b38,
title = "Antioxidative treatment for neuroprotection in glaucoma",
abstract = "Glaucoma is a neurodegenerative disease with progressive retinal ganglion cell apoptosis. IOP elevation is a modifiable proven risk factor for glaucoma. Although a lot of new medicines and surgeries for lowering IOP have come in, glaucoma is still a leading cause of blindness in the world, motivating us to search IOP-independent treatment. Accumulating evidences point to an association between oxidative stress and glaucoma. Increased level of oxidative DNA damage, lipid peroxidation, and protein oxidation and reduced antioxidative status were observed in serum, trabecular meshwork, and aqueous humor of human glaucoma subjects. Antioxidants protect retinal ganglion cell apoptosis from IOP elevation, optic nerve injury, inflammation, and impaired ocular blood flow in vivo and in vitro. Some population-based epidemiological studies showed that higher antioxidant intake reduced risk of glaucoma. This review focused on the present evidence that support the possibility of antioxidant neuroprotective treatment for glaucoma.",
keywords = "Antioxidant, Glaucoma, Mitochondria, Oxidative stress, Reactive oxygen species",
author = "Kenya Yuki",
year = "2014",
month = "5",
day = "1",
doi = "10.1007/978-4-431-54965-9_4",
language = "English",
isbn = "4431549641",
pages = "43--66",
booktitle = "Neuroprotection and Neuroregeneration for Retinal Diseases",
publisher = "Springer Japan",

}

TY - CHAP

T1 - Antioxidative treatment for neuroprotection in glaucoma

AU - Yuki, Kenya

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Glaucoma is a neurodegenerative disease with progressive retinal ganglion cell apoptosis. IOP elevation is a modifiable proven risk factor for glaucoma. Although a lot of new medicines and surgeries for lowering IOP have come in, glaucoma is still a leading cause of blindness in the world, motivating us to search IOP-independent treatment. Accumulating evidences point to an association between oxidative stress and glaucoma. Increased level of oxidative DNA damage, lipid peroxidation, and protein oxidation and reduced antioxidative status were observed in serum, trabecular meshwork, and aqueous humor of human glaucoma subjects. Antioxidants protect retinal ganglion cell apoptosis from IOP elevation, optic nerve injury, inflammation, and impaired ocular blood flow in vivo and in vitro. Some population-based epidemiological studies showed that higher antioxidant intake reduced risk of glaucoma. This review focused on the present evidence that support the possibility of antioxidant neuroprotective treatment for glaucoma.

AB - Glaucoma is a neurodegenerative disease with progressive retinal ganglion cell apoptosis. IOP elevation is a modifiable proven risk factor for glaucoma. Although a lot of new medicines and surgeries for lowering IOP have come in, glaucoma is still a leading cause of blindness in the world, motivating us to search IOP-independent treatment. Accumulating evidences point to an association between oxidative stress and glaucoma. Increased level of oxidative DNA damage, lipid peroxidation, and protein oxidation and reduced antioxidative status were observed in serum, trabecular meshwork, and aqueous humor of human glaucoma subjects. Antioxidants protect retinal ganglion cell apoptosis from IOP elevation, optic nerve injury, inflammation, and impaired ocular blood flow in vivo and in vitro. Some population-based epidemiological studies showed that higher antioxidant intake reduced risk of glaucoma. This review focused on the present evidence that support the possibility of antioxidant neuroprotective treatment for glaucoma.

KW - Antioxidant

KW - Glaucoma

KW - Mitochondria

KW - Oxidative stress

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84930728161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930728161&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-54965-9_4

DO - 10.1007/978-4-431-54965-9_4

M3 - Chapter

SN - 4431549641

SN - 9784431549642

SP - 43

EP - 66

BT - Neuroprotection and Neuroregeneration for Retinal Diseases

PB - Springer Japan

ER -